Recent Updates
Recently added Catalysts
ESTA Positive Sentiment

Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6

Key Takeaway: Establishment Labs Holdings Inc. is set to announce its financial results for Q1 2026 on May 6, 2026. The announcement will occur before market opening, followed by a conference call at 8:30 am ET. This event highlights the company's commitment to transparency and investor relations.
Price reaction · baseline $67.09 (2026-04-22 close) · hit after-hours · clean, no other ESTA news in the window
day 0 close · peak
-2.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Establishment Labs is dedicated to improving women's health.
  • The upcoming financial results may indicate positive growth.
  • The company is proactive in communicating with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~12 mo
Low dilution risk
Lead asset
Mesenchymal stem cells
Phase 1 · Chronic Myocardial Ischemia

Full Press Release Details

-Company to host conference call and webcast on May 7, 2026, at 8:00 a.m. ET (8:00 p.m. HKT)
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announcedthat it will report its first quarter 2026 financial results and provide recent corporate updates on May 7, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (8:00 p.m. HKT).

Conference Call and Webcast Information

The live webcast can be accessed by visiting the Company's website athttp://ir.zailaboratory.com. Participants must register in advance of the conference call.
Details are as follows:
• Registration link for webcast (preferred):https://edge.media-server.com/mmc/p/s7q4ox5h
All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-in details will be in the confirmation email which the participant will receive upon registering. A replay will be available shortly after the call and can be accessed by visiting the Company's website.

About Zai Lab

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health.
For additional information about Zai Lab, please visitwww.zailaboratory.comor follow us atwww.X.com/ZaiLab_Global.
For more information, please contact:Investor Relations:Christine Chiou / Cyan Liu+1 (917) 886-6929 / +86 195 3130 8895christine.chiou1@zailaboratory.com/cyan.liu@zailaboratory.comMedia:Shaun Maccoun / Xiaoyu Chen+1 (857) 270-8854 / +86 185 0015 5011shaun.maccoun@zailaboratory.com/xiaoyu.chen@zailaboratory.com

Frequently Asked Questions

When will Establishment Labs announce its Q1 2026 results?

Establishment Labs will announce its Q1 2026 financial results on May 6, 2026.

What time is the conference call for Q1 2026 results?

The conference call will take place at 8:30 am ET on May 6, 2026.

How can I participate in the conference call?

To participate in the conference call, dial 877-407-8037 (US & Canada).

What is the focus of Establishment Labs?

Establishment Labs focuses on improving women's health, particularly in breast aesthetics and reconstruction.

Last updated: Apr 23, 2026